Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microwave Ablation for Mild-to-Moderate Secondary Hyperparathyroidism
NCT02332135Unknown
- Start
- Jan 2015
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Randomised, open-label trial in secondary hyperparathyroidism (SHPT). Primary endpoints: Overall rate of achieving target for iPTH at 12 months and The change of iPTH level after MWA at 12 months. Status: unknown.
02
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT02332135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332135.